Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...
is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators ... Inogen One G5 system, Inogen TAV, and Inogen at Home.
This raises our optimism about the stock. In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC). This is likely to have witnessed a robust ...